ReviewFrontiers in oral health2026
From remote screening to precision prevention: responsible multimodal AI for risk prediction and equitable oral healthcare.
Review in Frontiers in oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) applications in oral healthcare have expanded considerably over the past decade. Deep-learning systems now report diagnostic performance exceeding 0.85 sensitivity and 0.90 specificity for several image-based tasks, with the highest pooled estimates reported in AI-assisted clinical photography for oral cancer and oral potentially malignant disorder (OPMD) detection (diagnostic odds ratio 68.4; AUC 0.938). These figures, however, mask three translational gaps. First, many studies often carry high risk of bias, lack external validation, and rest on heterogeneous reference standards. Second, datasets often provide limited demographic reporting, leaving uncertainty about model performance in the populations most likely to benefit from remote screening. Third, teledentistry and mHealth tools have outpaced the regulatory, validation, and fairness-auditing, and clinical-integration frameworks required for safe deployment. Preventive value emerges most clearly when AI is embedded in multimodal systems, such as imaging, sensors, behavioural feedback, clinician support rather than evaluated as an isolated classifier. Progress will be defined less by additional accuracy gains and more by external validation in diverse populations, transparent demographic reporting, equity-focused evaluation, and integration into prevention-oriented care pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.